I have expertise in rodent models of Parkinson’s disease, with a focus on alpha-synuclein. I completed my PhD at the University of Helsinki and did my first postdoc at University of Cambridge. After starting in the Lehtonen lab, I have been working on my own project transplanting human microglia and alpha-synuclein preformed fibrils. My main interest is in making better preclinical models to find new treatments for disease. When I’m not thinking about alpha-synuclein you can find me trying new beers and brewing my own, or then attending concerts (just kidding – I’m thinking about alpha-synuclein those times too ).